AMI Treatment Cost & Predictive Mortality Analysis

Acute Myocardial Infarction (AMI) – commonly known as a heart attack – is one of the most expensive and fatal chronic conditions treated within the US. This affects not only patient survival but challenges healthcare institutions and professionals to provide quality, cost-effective care. Large variations in diagnoses, treatments, and other factors result in varying levels of survival and costs.

In this Knowledge Sharing article, Steve Steklenski and Victor Wang examine the key factors affecting in-patient mortality and compare treatment cost on the basis of risk standardization and regional cost variation.

Their study analysis reveals substantial variations in AMI treatment costs, adjusted for quality and outcomes, at an institutional level. These findings can be used by institutions to further analyze drivers in quality care practices and outcomes. Payers and Accountable Care Organizations (ACO’s) can leverage these findings to improve patient care quality by partnering with those institutions demonstrating the highest quality and most cost-effective care.

Read the full article.